Green tea regulates cell cycle progression in oral leukoplakia

Head and Neck

Volumn 20, Issue 6, 1998, Pages 528-534

  Khafif, Avi ^a   Schantz, Stimson P ^a   Al Rawi, Mouwafak ^a,b   Edelstein, David ^b   Sacks, Peter G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b EAR AND THROAT HOSPITAL   (United States)

Author keywords

Cell cycle progression; EGCG; Green tea; Oral leukoplakia

Indexed keywords

EPIGALLOCATECHIN GALLATE; RETINOBLASTOMA PROTEIN;

ARTICLE; BEVERAGE; CANCER PREVENTION; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOPLAKIA; MOUTH CARCINOMA; PRECANCER; PRIORITY JOURNAL; TEA;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CATECHIN; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHILD, PRESCHOOL; HUMANS; LEUKOPLAKIA, ORAL; MODELS, BIOLOGICAL; MOUTH MUCOSA; PHYTOTHERAPY; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TEA;

EID: 0031858070     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199809)20:6<528::AID-HED7>3.0.CO;2-3     Document Type: Article

References (38)

1. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323: 795-801.
2. McDonald S, Haie C, Rubin P, Nelson D, Rivers DL. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment and prevention. Int J Radiat Oncol Biol Phys 1989;17:457-465.
3. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17: 449-456.
4. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck - long term follow-up. J Natl Cancer Inst 1994;86: 140-141.
5. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953;6: 963-968.
6. Pindborg JJ. Oral precancer. In: Barnes L, ed. Surgical pathology of the head and neck. New York: Marcel Dekker, 1985:279-331.
7. Hong WK, Endicott J, Itri LM, et al. 13-cis-Retinoic acid in the treatment of oral leukoplakia. New Engl J Med 1986;315:1501-1505.
8. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarker Prevent 1994;3:85-98.
9. Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 1995;22:169-180.
10. Yang CS, Wang Z-Y. Tea and cancer. J Natl Cancer Inst 1993;85:1038-1049.
11. Mukhtar H, Katiyar SK, Agarwal R. Green tea and skin-anticarcinogenic effect. J Invest Dermatol 1994;102:3-7.
12. Wang ZY, Agarwal R, Khan WA, Mukhtar H. Protection against benzo(a)pyrene and N-nitrosodiethyl-amine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis 1992;13:1491-1494.
13. Hirose M, Hoshiya T, Akagi K, Futakuchi M, Ito N. Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12 dimethylbenz(a)anthracene. Cancer Lett 1994;83:149-156.
14. Komori A, Yatsunami J, Okabe S, et al. Anticarcinogenic activity of green tea polyphenols. J Cancer Res Clin Oncol 1993;23:186-190.
15. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 1988;79:1067-1074.
16. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JFJ. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994;86: 855-858.
17. Wang ZY, Das M, Bickers DR, Mukhtar H. Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug Metab Disp 1988;16:98-103.
18. Liu L, Castonguay A. Inhibition of the metabolism and genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes by (+)-catechin. Carcinogen 1991;12:1203-1208.
19. Fujiki H, Yoshizawa S, Horiuchi T, et al. Anticarcinogenic effects of (-)-epigallocatechin gallate. Prevent Med 1992; 21:503-509.
20. Katiyar SK, Agarwal R, Wood GS, Mukhtar H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res 1992;52:6890-6897.
21. Hibasami H, Achiwa Y, Fujikawa T, Komiya T. Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res 1996;16:1943-1946.
22. Xu L, Schantz SP, Edelstein D, Sacks PG. A simplified method for the routine culture of normal oral epithelial (NOE) cells from upper aerodigestive tract mucosa. Methods Cell Sci 1996;18:31-39.
23. Sacks PG, Parnes SM, Gallick GE, et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988;48:2858-2866.
24. McCaffrey TA, Agarwal LA, Weksler BB. A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro. In Vitro Cell Devel Biol 1988; 24:247-252.
25. Nusse M, Beisker W, Hoffmann C, Tarnok A. Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements. Cytometry 1990;11:813-821.
26. Giaretti W, Nusse M. Light scatter of isolated cell nuclei as a parameter discriminating the cell cycle compartments. Methods Cell Biol 1994;41:389-400.
27. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 1990;82: 555-560.
28. Yamane T, Nakatani H, Kikuoka N, et al. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer Suppl 1996;77:1662-1667.
29. Sazuka M, Murakami S, Isemura M, Satoh K, Nukiwa T. Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 1995;98:27-31.
30. Suganuma M, Okabe S, Sueoka E, et al. A new process of cancer prevention mediated through inhibition of tumor necrosis factor-α expression. Cancer Res 1996;56: 3711-3715.
31. Cardon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995;147:545-560.
32. Xu L, Davidson BJ, Murty VVVS, et al. TP53 Gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 1994;59: 383-387.
33. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992;7:927-933.
34. Lippman SM, Shin DM, Lee JJ, et al. p53 And retinoid chemoprevention of oral carcinogenesis. Cancer Res 1995; 55:16-19.
35. Xu HJ, Xu K, Zhou Y, Li J, Benedict WF, Hu SX. Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc Natl Acad Sci USA 1994;91:9837-9841.
36. Richon VM, Rifkind RA, Marks PA. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Diff 1992;3:413-420.
37. KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 1997;18:1139-1148.
38. Hofmann F, Martelli F, Livingston DM, Wang Z. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Devel 1996;10:2949-2959.